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The ﬁlamentous ascomycete Ashbya gossypii is amenable to genetic manipulation and is an excellent
model system for studying eukaryotic cell biology. However, the number of selection markers in current
use for both targeted gene integration and disruption in this fungus are very limited. Therefore, the
Cre-loxP recombination system was adapted for use in A. gossypii and its effectiveness in recycling marker
genes was demonstrated by constructing both single and double deleted Agura3 and Agade1 auxotrophic
strains free of exogenous markers. In spite of its wide use, this is the ﬁrst report in which the Cre-loxP
system was applied to A. gossypii, opening new perspectives for targeted engineering of this fungus with
several promising biotechnological applications.
 2014 Elsevier Inc. All rights reserved.1. Introduction
The Cre-loxP recombination system of the bacteriophage P1 has
been shown to mediate efﬁcient recombination between directly
repeated loxP sites ﬂanking selectable markers in several organ-
isms, resulting in the excision of marker genes (Sternberg and
Hamilton, 1981; Sauer and Henderson, 1988; Orban et al., 1992;
Zhang et al., 2009). Cre-loxP-based systems have been widely used
to study gene function and to remove selection markers in fungi,
among which Saccharomyces cerevisiae (Sauer, 1987; Güldener
et al., 1996), Kluyveromyces lactis (Steensma and Ter Linde, 2001),
Kluyveromyces marxianus (Ribeiro et al., 2007), Schizosaccharomyces
pombe (Iwaki and Takegawa, 2004), Yarrowia lipolytica (Fickers
et al., 2003), Hansenula polymorpha (Qian et al., 2009), Cryptococcus
neoformans (Patel et al., 2010), Aspergillus nidulans (Forment et al.,
2006), Trichoderma reesei (Steiger et al., 2011), Neotyphodium
coenophialum, N. uncinatum and Epichloë festucae (Florea et al.,
2009).
Ashbya gossypii (syn. Eremothecium gossypii) is a ﬂavinogenic ﬁl-
amentous ascomycete (Ashby and Nowell, 1926; Kurtzman, 1995)
used for the industrial production of riboﬂavin (Stahmann et al.,
2000), which shares remarkable genomic similarities with the
budding yeast S. cerevisiae (Brachat et al., 2003; Dietrich et al.,
2004), being therefore considered an excellent model to study
ﬁlamentous growth (Wendland and Walther, 2005; Schmitz andPhilippsen, 2011). The high degree of gene homology and gene
order conservation (synteny) between the A. gossypii genome and
the S. cerevisiae genome have facilitated the assignment of poten-
tial functions to A. gossypii genes (Brachat et al., 2003; Dietrich
et al., 2004). Moreover, other A. gossypii features have made the
genetic manipulation of this fungus to be quite straightforward
when comparing to other ﬁlamentous fungi, among which: highly
efﬁcient homologous recombination, which allows the use of
PCR-based gene targeting tools (Steiner et al., 1995; Wendland
et al., 2000); haploid nuclei and unicucleated spores (Steiner
et al., 1995), which facilitate the isolation of stable homokaryotic
strains; and ability to freely replicate plasmids containing
S. cerevisiae autonomously replicating sequences (ARS) (Wright
and Philippsen, 1991) and to regulate gene expression using
S. cerevisiae promoters (Wendland et al., 2000; Kaufmann, 2009;
Ribeiro et al., 2010; Magalhães et al., 2014), making possible the
use of several tools already available to manipulate S. cerevisiae.
Although a wide range of molecular tools exist to genetically
engineer A. gossypii, the number of selection markers in current
use is limited. The absence of a known sexual cycle in A. gossypii
has hindered the use of classical genetics approaches in this fungus
(Wendland et al., 2011). Thus, the molecular characterization of A.
gossypii genes has relied on reverse genetics approaches. However,
only four marker genes are available for PCR-based gene targeting
in A. gossypii, which has hampered the disruption and/or integra-
tion of multiple genes in the same strains. The existent markers
are: (1) the S. cerevisiae LEU2 gene fused with its own promoter
and terminator (Alberti-Segui et al., 2001), which can only be used
as auxotrophic marker for gene manipulations in stable Agleu2
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TEF2 (ScTEF2) promoter and terminator (GEN3) (Wendland et al.,
2000); (3) the Streptomyces noursei natr gene ﬂanked by the
S. cerevisiae PDC1 (ScPDC1) promoter and terminator (NATPS)
(Hoepfner in Kaufmann, 2009); and (4) a hygr gene fused to the
promoter and terminator sequences of the A. gossypii LEU2
(AgLEU2) gene (Revuelta in Schlüpen, 2003; Jiménez et al., 2008).
Because this last marker cassette contains sizeable homology
regions to the AgLEU2 locus, when used for targeted engineering
it can direct integration into the AgLEU2 locus rather than into
the desirable target site.
The ability to rescue drug marker genes from the A. gossypii gen-
ome would therefore offer new perspectives in what concerns A.
gossypii manipulation. Hence, the aim of this work was to develop
a Cre-loxP-based system to remove and reuse selection markers in
A. gossypii. To achieve this goal, several marker cassettes and Cre-
expressing plasmids were constructed and successfully used to
excise the selection markers used to delete two model genes, the
AgURA3 (AEL059W) gene and the predicted AgADE1 (AER221W)
open reading frame (ORF). These genes were chosen because their
deletion not only should provide easy phenotype identiﬁcation as
would result in new auxotrophic strains, further expanding the
molecular toolbox available for A. gossypii.
2. Materials and methods
2.1. Strains and media
A. gossypii ATCC 10895 strain, kindly provided by Prof. P. Phil-
ippsen (University of Basel) was used as the background for all
deletions. Strains generated in this study are listed in Table 1. A.
gossypii strains were grown at 30 C on agar-solidiﬁed Ashbya full
medium (AFM; 10 g/l tryptone, 10 g/l yeast extract, 20 g/l glucose,
1 g/l myo-inositol), containing 150 lg/ml geneticin (G418)
(Sigma–Aldrich Química, Sintra, Portugal), 50 lg/ml nourseothricin
(clonNAT) (WERNER BioAgents, Jena, Germany) or 5 lg/ml phleo-
mycin (InvivoGen, Toulouse, France) for selection and maintenance
of transformants. A. gossypii spores were prepared and stored as
described by Ribeiro et al. (2010), with the exception that the
mycelium was digested using 4 mg/ml Lysing Enzymes fromTable 1
Strains and plasmids used in this study.
Strain or
plasmid
Relevant feature(s)
A. gossypii strains
ATCC 10895 Parent strain
Agura3GEN3 Derived from ATCC 10895; Agura3D::loxP-GEN3-loxP
Agade1NATPS Derived from ATCC 10895; Agade1D::loxP-NATPS-loxP
Agura3 Derived from Agura3GEN3; Agura3D::loxP
Agade1 Derived from Agade1NATPS; Agade1D::loxP
Agura3ade1GEN3 Derived from Agura3; Agura3D::loxP Agade1D::loxP-GEN3-loxP
Agura3ade1 Derived from Agura3ade1GEN3; Agura3D::loxP Agade1D::loxP
Plasmids
pGEN3 GEN3 cassette conferring resistance to G418: comprises the E. coli
the S. cerevisiae TEF2 promoter and terminator; ampicilin resistan
pUG66 bleMX cassette conferring resistance to phleomycin: comprises th
control of the A. gossypii TEF promoter and terminator ﬂanked by
pUC19NATPS NATPS cassette conferring resistance to clonNAT: comprises the Str
PDC1 promoter and terminator; ampicillin resistance
pUGGEN3 Derivative of pUG66 with the GEN3 cassette from pGEN3 instead
pUGNATPS Derivative of pUG66 with the NATPS cassette from pUC19NATPS i
pUGBLE3 Derivative of pUGGEN3 with the bler gene from pUG66 under the c
pNatCre natMXmarker conferring resistance to clonNAT; comprises the nat
and terminator; bacteriophage P1 cre gene under the control of th
ARSH-CEN6 replication sequences from S. cerevisiae; ampicillin res
pAgNatCre Derivative of pNatCre with the cre gene under the control of the
pAgBleCre Derivative of pAgNatCre with the bleMX marker from pUG66 in pTrichoderma harzianum (Sigma–Aldrich Química, Sintra, Portugal).
Agar-solidiﬁed Synthetic Complete (SC) medium (Sherman et al.,
1986) buffered with 0.1 M sodium-phosphate buffer (pH 7.0), lack-
ing uracil and/or adenine, or supplemented with 5 mM uridine,
uracil and adenine (AppliChem GmbH, Darmstadt, Germany) was
used for phenotype characterization. When indicated, 5-ﬂuoroo-
rotic acid (5-FOA) (Sigma–Aldrich Química, Sintra, Portugal) was
added to agar-solidiﬁed AFM at a ﬁnal concentration of 1 mg/ml.
E. coli TOP10 (Invitrogen, Carlsbad, CA) served as plasmid host
and was grown on agar-solidiﬁed LB medium (Sambrook and
Russell, 2001) containing 100 lg/ml ampicillin (Sigma–Aldrich
Química, Sintra, Portugal). Plasmids were maintained in a
permanent culture at 80 C in 2 ml aliquots with 15% (w/w)
glycerol.
2.2. Molecular methods
DNA manipulations were carried out using standard procedures
(Sambrook and Russell, 2001). Plasmid DNA was isolated from
E. coli using the GenElute Plasmid Miniprep Kit (Sigma–Aldrich
Química, Sintra, Portugal). PCR reactions were performed using
NZYTaq DNA polymerase (NZYTech, Lisbon, Portugal) or Phusion
High-Fidelity DNA polymerase (Finnzymes, Espoo, Finland). All
primers used in this work are listed in Table 2 and were obtained
from Frilabo (Maia, Portugal). PCR fragments were puriﬁed using
the QIAquick PCR Puriﬁcation Kit (QIAGEN, Hilden, Germany) and
DNA fragments were recovered from agarose gels using the
QIAquick Gel Extraction Kit (QIAGEN, Hilden, Germany). The
restriction enzymes used in this study were purchased from New
England BioLabs (Ipswich, USA) or NZYTech (Lisbon, Portugal). T4
DNA ligase was purchased from Promega (Madison, USA).
Transformation of A. gossypii was carried out as described by
Wendland et al. (2000), using 30 lg of DNA for integration of dele-
tion cassettes, or 5 lg of DNA for plasmid insertion. A. gossypii
genomic DNA was extracted as follows. A piece of mycelium col-
lected from the border of A. gossypii colonies was transferred to
microcentrifuge tubes containing 200 ll of autoclaved DNA extrac-
tion buffer (50 mM NaCl, 1 mM EDTA pH 8.0, 10 mM Tris–HCl pH
8.0, and 0.5% (v/v) Triton X-100) and quickly mixed by vortexing.
100 ll of phenol:chloroform:isoamyl alcohol (25:24:1) were sub-Reference
Prof. P. Philippsen
This work
This work
This work
This work
This work
This work
kanr gene from transposon Tn903 under the control of
ce
Wendland et al. (2000)
e bacterial bler gene from transposon Tn5 under the
two loxP sequences; ampicillin resistance
Gueldener et al. (2002)
eptomyces noursei nat1 gene ﬂanked by the S. cerevisiae D. Hoepfner in
Kaufmann (2009)
of the bleMX cassette This work
nstead of the bleMX cassette This work
ontrol of the S. cerevisiae TEF2 promoter and terminator Ribeiro et al. (2013)
1 gene under the control of the A. gossypii TEF promoter
e S. cerevisiae GAL1 promoter and CYC1 terminator;
istance
Steensma and Ter
Linde (2001)
S. cerevisiae ADH2 promoter This work
lace of the natMX cassette This work
Table 2
Oligonucleotide primers used in this study. Underlined letters are nucleotide sequences complementary to the gene deletion regions. Recognition sequences for restriction
enzymes are in bold.
Name Sequence (50–30)
G1 GCTAGGGATAACAGGGTAAT
G2 CCGCTCGAGGATCTGATGAGGCCGTCT
G3 GATGGTGTAGGCTCCACATCACAGTAAGCATTTGTATAAGGCTGATCACATAGGGTGCTACCGACCCTAGCCATTGCCACGCAGGTCGACAACCCTTAAT
G4 GGGCATATAATTACAAAAAGGTTGCTGAGATGGTAATCGGCGGTGGAATCCGCCTATATACTGTGGGCGCCAGCGATAGAGCATAGGCCACTAGTGGATC
U1 CCATTGCCACATGTCAACGAAATC
U2 GTGTTGGATGCATGCTACTGAAC
G5 TCGCAGACCGATACCAGGATC
U3 AATCGCTCGAGCAACTCATTGG
N1 GAAGATCTTCCCTGCAGAACCGTTACGGTA
N2 CCGCTCGAGCCTGCAGCCAAACAGTGTT
N3 CCAGGCAGCGCGAGCTTGACTCTGGTCTATGGCCAATTTAACAGCCCCATATAGACAAGATATATATAGAGAGATAGCAGGCAGGTCGACAACCCTTAAT
N4 CACATCTCCATTTATCACTTAAAATTATTTAACATTTTAAAAGTACATCATTTTACCATTTCGCGCCTGTAAGTGCTTCGGCATAGGCCACTAGTGGATC
A1 CAATGCGTCTCGAGGAATTTGCTCG
A2 TCGGGTGACGTTAGCGCATCA
A3 AGAAGCAAGCGAGCGACTACG
N5 GATTCGTCGTCCGATTCGTC
AH1 CGAGCTCGCAAAGGGGCAAAACGTAG
AH2 CGGAATTCCGTGAGTTTCTGGAATAGACATTG
ScTEFt_EcoRI CGGAATTCTCGATGAGTTTTTCTAAGAG
ScTEFp_NcoI TCTATTCCATGGTAATTATAGTTCGTTGACCG
Ble GCAGGTCGACAACCCTTAAT
Ble_EcoRI CGGAATTCTCATGAGATGCCTGCAAG
qPCRAgACT1_F TCGTTGCCACACGCCATTT
qPCRAgACT1_R AAAGGAGTAGCCACGTTCCGATAG
qPCRCRE_F CGTACTGACGGTGGGAGAATGTTA
qPCRCRE_R TCCATCGCTCGACCAGTTTAGT
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with intercalary cooling on ice. After centrifugation for 15 min at
maximum speed, 20 ll of the upper aqueous phase were diluted
with 80 ll of water. 1–2 ll of these DNA samples were used as
template for PCR ampliﬁcation.2.3. DNA constructs
The deletion cassettes loxP-GEN3-loxP and loxP-NATPS-loxP
were constructed as follows. The GEN3 cassette was ampliﬁed from
pGEN3 (Wendland et al., 2000) using primers G1 and G2 (Table 2)
and the NATPS cassette ampliﬁed from pUC19NATPS (Hoepfner in
Kaufmann, 2009) with primers N1 and N2 (Table 2). Both frag-
ments were digested with BglII and XhoI, and cloned between the
loxP sequences of BglII/XhoI digested pUG66 (Gueldener et al.,
2002) to create pUGGEN3 and pUGNATPS, respectively. A loxP-
BLE3-loxP cassette was also generated as described in Ribeiro
et al. (2013). Brieﬂy, the entire pUGGEN3 sequence, with the
exception of the kanr gene, was ampliﬁed with the primers
ScTEFt_EcoRI and ScTEFp_NcoI (Table 2) and the bler gene obtained
by PCR from plasmid pUG66 with the primers Ble and Ble_EcoRI
(Table 2). Both PCR fragments were digested with EcoRI and NcoI
and ligated to create pUGBLE3.
For deletion of the AgURA3 (AEL059W) gene, the loxP-GEN3-loxP
cassette was obtained by PCR from pUGGEN3 with primers G3 and
G4 (Table 2). For deletion of the AgADE1 (AER221W) ORF, either
loxP-GEN3-loxP or loxP-NATPS-loxP cassettes were obtained by
PCR from pUGGEN3 or pUGNATPS, respectively, with primers N3
and N4 (Table 2). The ampliﬁed deletion modules comprised the
resistance cassettes ﬂanked by loxP sequences and 80 bp guide
sequences with homology to the 50 and 30 untranslated regions
(UTRs) of the target loci, to ensure recombination in the correct
location and direction in the genome.
Plasmids pAgNatCre and pAgBleCre were constructed from
pNatCre (Steensma and Ter Linde, 2001), a shuttle vector that
harbors ARSH-CEN6 elements from S. cerevisiae, the natMX selective
marker and the bacteriophage P1 cre gene ﬂanked by theS. cerevisiae GAL1 (ScGAL1) promoter and CYC1 (ScCYC1) terminator.
For that, a 599 bp fragment containing the S. cerevisiae ADH2
(ScADH2) promoter, from position 872,712–873,310 on S. cerevisiae
chromosome XIII, was ampliﬁed from the strain CEN.PK 113-7D
genomic DNA with primers AH1 and AH2 (Table 2). The ampliﬁed
fragment was digested with the restriction enzymes SacI and EcoRI
and cloned between the SacI/EcoRI sites of pNatCre in place of the
ScGAL1 promoter. This new plasmid was named pAgNatCre. The
pAgBleCre plasmid was obtained by the substitution of the natMX
cassette from pAgNAtCre with the bleMX cassette from pUG66 with
the restriction enzymes BglII and SacI. All plasmids used and
generated in this study are listed in Table 1.2.4. Isolation of homokaryotic mutants and diagnostic PCR
Clonal selection of A. gossypii homokaryotic mutants was per-
formed through the isolation of single uninucleated haploid spores
from primary heterokaryotic transformants. For that, different
dilutions of spores harvested from primary transformants were
spread onto selective AFM plates with a guide line drawn in the
bottom. After germination for approximately 24 h, plates were
visually analyzed with a Nikon Diaphot 300 inverted microscope
(Sony, Portugal) and single germlings were marked, isolated with
a sterile scalpel and transferred to new selective AFM plates. The
absence of the gene of interest was tested via diagnostic PCR.
PCR reactions were carried out in 25 ll reaction mixtures with
1–2 ll DNA template, 0.35 lM of each primer, 200 lM dNTP mix,
0.05 U/ll NZYTaq and NZYTaq buffer with 1.5 mM MgCl2 provided
by the manufacturer (NZYTech, Lisbon, Portugal). PCR conditions
were: 5 min at 95 C, 35 cycles of 95 C for 45 s, 50 C for 2 min
(with increments of 0.3 C per cycle), 72 C for 1 min 30 s, and a
ﬁnal extension at 72 C for 5 min. Correct integration of the loxP-
GEN3-loxP cassette in the AgURA3 and AgADE1 loci was veriﬁed
using the primer pairs U1/U2, G5/U2 and U3/U2 (Table 2), and
A1/A2, G5/A3 and A1/A3 (Table 2), respectively. Integration of
the loxP-NATPS-loxP cassette in the AgADE1 locus was conﬁrmed
using the primer pairs A1/A2, A1/N5 and A1/A3 (Table 2).
Fig. 1. Schematic representation of the strategy used for gene deletion and marker rescue in A. gossypii, and veriﬁcation PCRs of the generated mutants, for which the A.
gossypii ATCC 10895 parent strain (PS) was used as control. (A) Construction of the A. gossypii Agura3 (US) marker-free strain. The AgURA3 gene (AEL059W) was replaced by the
loxP-GEN3-loxP cassette, which was ampliﬁed with the primer pair G3/G4, yielding the strain Agura3GEN3 (UGS). This strain was subsequently transformed with the Cre-
expressing plasmid pAgNatCre and excision of the GEN3 marker occurred after transient expression of the Cre recombinase. (B) Veriﬁcation of the integration of the loxP-
GEN3-loxP cassette in the AgURA3 locus and conﬁrmation of its excision. (C) Construction of the A. gossypii Agade1 (AS) marker-free strain. The AgADE1 gene (AER221W) was
replaced by the loxP-NATPS-loxP cassette, which was ampliﬁed with the primer pair N3/N4, yielding the strain Agade1NATPS (ANS). This strain was transformed with the Cre-
expressing plasmid pAgBleCre and the NATPS marker was excised as described above. (D) Veriﬁcation of the integration of the loxP-NATPS-loxP cassette in the AgADE1 locus
and conﬁrmation of its excision. (E) Construction of the marker-free A. gossypii Agura3ade1 (UAS) double deletion strain. The GEN3 marker, which had been excised from the
Agura3 strain, was used again to successfully delete the AgADE1 gene in this strain, yielding the strain Agura3ade1GEN3 (UAGS). This strain was transformed with the Cre-
expressing plasmid pAgBleCre and the GEN3marker was again excised after transient expression of the Cre recombinase. (F) Veriﬁcation of the integration of the loxP-GEN3-
loxP cassette in the AgADE1 locus of the Agura3 strain and conﬁrmation of its excision.
4 T.Q. Aguiar et al. / Fungal Genetics and Biology 68 (2014) 1–8The positions of the primers and expected PCR amplicon sizes are
given in Fig. 1.2.5. Cre recombinase expression and marker cassette excision
For excision of the loxP-ﬂanked marker cassettes, the mutant
Agura3GEN3 was transformed with the Cre-expressing plasmid
pAgNatCre and the Agade1NATPS and Agura3ade1GEN3 mutants
with the plasmid pAgBleCre. The transformants were selected on
agar-solidiﬁed AFM containing 50 g/l glucose and 50 lg/ml of
clonNAT or 5 lg/ml of phleomycin, depending on the resistance
conferred by the plasmid. To express the Cre recombinase, positive
transformant colonies were grown for 1 week on agar-solidiﬁed
AFM containing 10 g/l ethanol as sole carbon source plus the corre-
sponding antibiotic selection. Simultaneously, the same transfor-
mants were also grown on selective AFM containing 50 g/l
glucose, to test whether the expression of the Cre recombinasewould be different in these conditions. Subsequently, spores har-
vested from these plates were spread onto agar-solidiﬁed AFM
without selection, for plasmid loss. Small patches from the edge
of each new mycelial colony were transferred to agar-solidiﬁed
AFM containing G418 and/or clonNAT (depending on the resis-
tance conferred by the deletion cassette used) and agar-solidiﬁed
AFM without antibiotic. No growth in plates containing antibiotic
indicated successful excision of the marker cassettes through
recombination of the loxP sequences. The removal of the
loxP-ﬂanked marker cassettes was further conﬁrmed by PCR and
stable homokaryotic mutants free of exogenous markers were
isolated as described above.2.5.1. Quantitative PCR
For the expression analysis of the cre recombinase, mycelia
from a colony of Agura3GEN3 transformed with the Cre-expressing
plasmid pAgNatCre were harvested (in triplicate) after 4 days of
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either 10 g/l ethanol or 50 g/l glucose. Mycelia from untransformed
Agura3GEN3 grown for 4 days on agar-solidiﬁed AFM containing
10 g/l ethanol or 50 g/l glucose were also harvested in triplicate.
Total RNA was extracted with the RNeasy Plant Mini kit (QIAGEN,
Hilden, Germany) using the manufacturer’s instructions for
ﬁlamentous fungi and its concentration and purity was determined
as previously described (Aguiar et al., 2014). After treatment with
DNase I (Thermo Fisher Scientiﬁc, Loures, Portugal), 1 lg of total
RNA was reverse transcribed using the NZY First-Strand cDNA Syn-
thesis Kit (NZYTech, Lisbon, Portugal). Quantitative PCR (qPCR)
analyses were performed on a Bio-Rad (Hercules, CA) CFX 96
real-time PCR system as previously described (Aguiar et al.,
2014), with the primer pairs shown in Table 2. Each cDNA (1:10)
sample was analyzed in duplicate and the average cycle threshold
was calculated. Relative expression levels were determined with
the 2DDCT (Livak) method, using the experimentally determined
ampliﬁcation efﬁciency of the primers. The cre expression levels
were normalized to the expression level of actin (AgACT1) for each
strain in each condition.3. Results
3.1. Constructs generated for marker recycling in A. gossypii
New disruption cassettes for use in A. gossypii, which could be
excised after being used to screen for a genetic modiﬁcation and
then reused to produce multiple gene deletions in the same strain,
were constructed using as backbone the plasmid pUG66
(Gueldener et al., 2002). The loxP-GEN3-loxP and loxP-NAPS-loxP
cassettes were obtained by replacing the bleMX unit located
between the two loxP sites in plasmid pUG66 with the GEN3 and
NATPS units from plasmids pGEN3 (Wendland et al., 2000) and
pUC19NATPS (Hoepfner in Kaufmann, 2009), respectively, yielding
plasmids pUGGEN3 and pUGNATPS (Fig. 2). The bler gene from
transposon Tn5, which confers resistance to phlemoycin
(Gatignol et al., 1987), was used to create the new heterologous
dominant drug resistance marker cassette loxP-BLE3-loxP, as
described in Ribeiro et al. (2013). The bler gene was isolated byFig. 2. Schematic illustration of the loxP-ﬂanked marker modules constructed and corr
homologous integrants to the number of genotyped transformants. The marker cassette
between the loxP sites of pUG66 using the indicated enzymes. The bler gene was PCR
terminator sequences of pUGGEN3. Three pUG plasmids containing the GEN3 (pUGGEN
ﬂanked by loxP-sequences were obtained. *Ribeiro et al. (2013).PCR from plasmid pUG66 and placed between the ScTEF2 promoter
and terminator in plasmid pUGGEN3, yielding plasmid pUGBLE3
(Fig. 2).
New plasmids for transient expression of the Cre recombinase
in A. gossypii were constructed using as backbone the replicative
ARSH-CEN6 plasmid pNatCre (Steensma and Ter Linde, 2001). This
plasmid harbors a Cre expression cassette where the cre gene is
ﬂanked by the ScGAL1 promoter and ScCYC1 terminator sequences.
Several GAL pathway genes are absent in the A. gossypii genome
(Hittinger et al., 2004), including the ScGAL1 homolog, hampering
its growth on galactose. Hence, the ScADH2 promoter was used
instead to mediate the Cre recombinase expression in A. gossypii.
In the plasmid pAgNatCre, the 467 bp ScGAL1 promoter was there-
fore substituted with the 599 bp ScADH2 promoter. Plasmid pAg-
BleCre was obtained by substituting the natMX drug marker in
pAgNatCre with the bleMX expression cassette from plasmid
pUG66. The usable range of phleomycin concentrations for selec-
tion of A. gossypii phleomycin-resistant colonies was determined
and the optimal concentration for selection was found to be
5 lg/ml phleomycin (in agar-solidiﬁed AFM).3.2. Deletion of the AgURA3 gene and generation of an uracil
auxotrophic strain
As a model to test the functionality of the Cre-loxP system in A.
gossypii, the entire coding region of the AgURA3 (AEL059W) gene
was deleted from the A. gossypii genome using the loxP-GEN3-loxP
cassette ﬂanked by 80 bp guide sequences with homology to the
AgURA3 50 and 30 UTRs. Homologous integration of this deletion
module within the AgURA3 locus resulted in the replacement of
AgURA3 by the loxP-GEN3-loxP cassette with its transcriptional ori-
entation corresponding to that of the deleted gene (Fig. 1A). Of the
primary transformants randomly screened 53% were heterokary-
otic, containing nuclei with both wild type and null alleles of
AgURA3 (Fig. 2). After a single spore puriﬁcation step, diagnostic
PCR indicated the sole presence of the mutant allele in the
Agura3GEN3 strain (Fig. 1B).
Deletion of the AgURA3 gene caused uridine/uracil auxotrophy,
being the homokaryotic Agura3GEN3 strain unable to grow onesponding targeting efﬁciencies, estimated by the ratio of the number of positive
s GEN3 and NATPS were PCR-ampliﬁed from pGEN3 and pUC19NATPS, and cloned
-ampliﬁed from pUG66 and cloned between the S. cerevisiae TEF2 promoter and
3, 4264 bp), NATPS (pUGNATPS, 3888 bp) and BLE3 (pUGBLE3, 3859 bp) cassettes
Fig. 3. qPCR analysis of the cre expression in Agura3GEN3 transformed (+) or not ()
with the Cre-expressing plasmid pAgNatCre. The strains were grown for 4 days on
agar-solidiﬁed AFM containing 50 g/l glucose or 10 g/l ethanol. The cre expression
levels were normalized to the expression level of actin (AgACT1). Data represents
the mean ± SD of three biological replicates.
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ium was supplemented with uridine and uracil the Agura3GEN3
strain grew similarly to the parent strain, which did not happen
when the medium was supplemented with uracil alone (Fig. 4).
Moreover, contrary to the parent strain, the Agura3GEN3 strain
was able to grow on agar-solidiﬁed AFM containing 1 mg/ml
5-FOA (Fig. 4).
3.3. Transient expression of Cre recombinase and marker rescue
The Agura3GEN3 strain was transformed with the plasmid
pAgNatCre to allow the transient expression of Cre recombinase.
Transformants were selected on rich AFM containing clonNAT
and 50 g/l glucose. Spores harvested from a randomly selected
transformant colony were grown for 1 week on agar-solidiﬁed
AFM containing clonNAT and 10 g/l ethanol as sole carbon source.
The spores collected after this period were spread onto non-selec-
tive AFM, to promote plasmid loss, and the sensitivity of the result-
ing colonies to clonNAT and G418 was tested. Of the 39 mycelialFig. 4. Characterization of the A. gossypii Agura3 and Agade1 null mutants growth on aga
and/or adenine (ADE). The Agura3mutants were also grown on agar-solidiﬁed AFM suppl
parental strain (ATCC 10895) was used as control. Red colored Agade1 colonies were only
(For interpretation of the references to color in this ﬁgure legend, the reader is referredcolonies screened none was able to grow on AFM containing clon-
NAT, indicating that all had lost the plasmid that contained the nat-
MX resistance marker after only one passage in non-selective
conditions. Thirty-six colonies were also unable to grow on AFM
containing G418, from which the GEN3 marker had been looped
out and lost. After a single spore puriﬁcation step, the excision of
the GEN3 cassette from the Agura3 locus was conﬁrmed by PCR
(Fig. 1B). This homokaryotic strain free of exogenous marker genes
was named Agura3.
To test whether the excision of the GEN3 cassette also occurred
in glucose-containing medium, spores from the same randomly
selected transformant colony were simultaneously grown on
agar-solidiﬁed AFM containing clonNAT and 50 g/l glucose. In this
case, 42 of the 49 mycelial colonies screened also lost their resis-
tance to G418. Moreover, no statistically signiﬁcant differences
were found in the cre transcript levels between these conditions
(p = 0.159), although a tendency was observed for lower expression
of the Cre recombinase in glucose-containing medium (Fig. 3).
To assess the occurrence of background excision (i.e. Cre recom-
binase-independent excision), the untransformed Agura3GEN3
strain was also grown for 1 week on agar-solidiﬁed AFM containing
either 10 g/l ethanol or 50 g/l glucose. Of the 63 mycelial colonies
screened for each condition none was sensitive to G418. Moreover,
the transcript levels of the cre gene in this strain were undetectable
(Fig. 3). Altogether, these data indicate that the excision of the
GEN3 cassette was dependent on the expression of the Cre
recombinase.3.4. Deletion of the AgADE1 gene and generation of a stable adenine
auxotrophic strain
To demonstrate the versatility of the developed Cre-loxP sys-
tem, the predicted AgADE1 (AER221W) ORF was deleted using the
loxP-NATPS-loxP cassette, with a targeting efﬁciency of 6%
(Fig. 2). The correct integration of this deletion cassette was veri-
ﬁed by PCR, as shown in Fig. 1D, and the resulting homokaryotic
strain was named Agade1NATPS.r-solidiﬁed SC medium supplemented (+) or not () with uracil (URA), uridine (URI)
emented with 5-FOA (1 mg/ml). Plates were incubated for 3–5 days at 30 C and the
observed when the concentration of adenine in the mediumwas lowered to 0.2 mM.
to the web version of this article.)
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mid pAgBleCre, transformants were selected on AFM containing
phleomycin and 50 g/l glucose, and Cre recombinase was tran-
siently expressed as described above. Following this strategy, the
loxP-ﬂanked NATPS cassette could be looped out of the chromo-
somal DNA of Agade1NATPS transformant colonies. After a single
spore puriﬁcation step, a homokaryotic Agade1 strain free of mar-
ker genes (Fig. 1D) and auxotrophic for adenine (Fig. 4) was
obtained.3.5. Demonstration of marker recycling by deletion of the AgADE1 gene
from the genome of the Agura3 strain
To demonstrate the successful recycling of the GEN3marker, the
AgADE1 ORF was also deleted from the genome of the Agura3 strain
using the loxP-GEN3-loxP cassette previously used to delete the
AgURA3 ORF, which was ﬂanked by 80 bp guide sequences with
homology to the AgADE1 50 and 30 UTRs. The correct integration
of the deletion cassette in the AgADE1 locus was veriﬁed by PCR
as shown in Fig. 1F. Homokaryotic Agura3ade1GEN3 mutants were
obtained after a single spore puriﬁcation step (Fig. 1F).
Physiological characterization of this mutant revealed that it
was auxotrophic for both uridine/uracil and adenine (Fig. 4). This
strain also continued to be resistant to 5-FOA (1 mg/ml).
To excise again the GEN3 cassette from this strain, it was trans-
formed with the Cre-expressing plasmid pAgBleCre for transient
expression of the Cre recombinase, as described in Section 2. Of
the 40 mycelial colonies screened after the transient expression
protocol, 36 were unable to grow on AFM containing G418, sug-
gesting that the GEN3 marker had been lost again. After a single
spore puriﬁcation step, the excision of the GEN3 cassette from
the Agade1 locus was conﬁrmed by PCR (Fig. 1F). This homokary-
otic strain free of exogenous marker genes was named Agura3ade1.4. Discussion
Here, the Cre-loxP recombination systemof the bacteriophage P1
was adapted to genetically engineerA. gossypii in a targetedway and
allow the removal and reuse of the selection markers used during
the process. Three heterologous recyclable drug marker cassettes
and two Cre recombinase expression vectors for use in A. gossypii
were created and successfully used to generate stable Agura3 and
Agade1 auxotrophic strains free of exogenous selectable markers.
The AgURA3 gene encodes the orotidine-50-phosphate decar-
boxylase involved in the biosynthesis of pyrimidines (Pompejus
et al., 1999) and its deletion caused uridine/uracil auxotrophy,
and conferred resistance to 5-FOA. In the parent strain, growth
was hampered by the presence of 5-FOA in the medium, which
indicates that the AgUra3p converts 5-FOA into 5-ﬂuorouracil, a
toxic compound that causes cell death (Boeke et al., 1984). There-
fore, the use of the AgURA3 gene as a bidirectionally selectable
marker (conferring uridine/uracil prototrophy and 5-FOA sensitiv-
ity) may be considered in future A. gossypii engineering projects.
However, it is worth noting that in previous reports neither the
S. cerevisiae URA3 nor the E. coli pyrF genes were able to comple-
ment uracil auxotrophy in A. gossypii Agura3 mutants (Pompejus
et al., 1999). Therefore, efforts are now being made to develop an
expression cassette that can complement the AgURA3 auxotrophy.
Based on the analysis of the annotated genome sequence of A.
gossypii (http://agd.vital-it.ch; Gattiker et al., 2007), the AER221W
ORF (AgADE1) was found to be homologous to the S. cerevisiae
ADE1 gene. In S. cerevisiae, this gene encodes the N-succinyl-5-
aminoimidazole-4-carboxamide ribotide (SAICAR) synthetase
involved in the purine biosynthetic pathway and its deletion causes
adenine auxotrophy, and vacuolar accumulation of red-coloredpurine precursors when the exogenous adenine supplied is limited
(Fischer, 1969). Both these phenotypes were also observed in the A.
gossypii Agade1 null mutants (Fig. 4). Previously, the deletion of the
AgADE4 gene had also been shown to cause adenine auxotrophy in
A. gossypii (Jiménez et al., 2005), but not the red pigmentation phe-
notype characteristic of ade1 and ade2 mutants (Fischer, 1969).
For S. cerevisiae, several recyclable marker cassettes and
Cre-expressing plasmids are available (Güldener et al., 1996;
Steensma and Ter Linde, 2001; Gueldener et al., 2002). Unfortu-
nately, these cannot be used in A. gossypii for several reasons. First,
most of the available cassettes are not heterologous to the A. gossypii
genome, as they contain the A. gossypii TEF promoter and terminator
sequences. Second, the heterologous cassettes available are auxo-
trophic markers, therefore requiring the existence of auxotrophic
strains. Third, the cre gene present in the available plasmids is under
the regulation of the ScGAL1 promoter (Steensma and Ter Linde,
2001; Gueldener et al., 2002), which cannot be used in A. gossypii
because this fungus lacks pathways for the utilization of galactose
in its genome (Dünkler and Wendland, 2007).
Therefore, the heterologous GEN3 and NATPS markers widely
used for PCR-based gene targeting in A. gossypii were adapted to
contain loxP ﬂanking sequences and successfully used to select
Agura3 and Agade1mutants. A new loxP-ﬂanked heterologous drug
resistance cassette was also constructed, which comprises the bler
gene from transposon Tn5 fused to the ScTEF2 promoter and
terminator (BLE3). This marker cassette renders resistance to
phleomycin, a copper-containing antibiotic that acts by interfering
with DNA synthesis (Gatignol et al., 1987). Although the BLE3mar-
ker was not used to delete any of the genes presented here, it was
successfully used to generate and select A. gossypii Aggas1agas1b
null mutants (Ribeiro et al., 2013), with a targeting efﬁciency of
approximately 15% (Fig. 3).
In the generated Cre-expressing plasmids, the ScGAL1 promoter
was substituted by the ScADH2 promoter to allow transient expres-
sion of the Cre recombinase in A. gossypii. In S. cerevisiae, the regu-
lation of the ScADH2 promoter is well studied, being its expression
repressed several hundred-fold in the presence of glucose and acti-
vated when the glucose is depleted from the medium (Lee and
DaSilva, 2005). In A. gossypii, as this promoter had never been used
before little was known about its functionality, although previous
observations had shown that the transcription of the A. gossypii
ScADH2 homolog (AAR084W) was also repressed by the presence
of glucose in the medium (our microarray data). In this study,
the expression of the Cre recombinase on agar-solidiﬁed AFM con-
taining glucose was slightly lower than when ethanol was used
instead as carbon source, but this difference was not statistically
signiﬁcant (Fig. 3). On the other hand, no cre transcripts were
detected in strains lacking Cre-expressing plasmids, neither could
be detected Cre recombinase-independent excisions of the marker
cassettes. The constructed plasmids thus allowed the transient
expression of the Cre recombinase, necessary to generate the
mutant strains free of exogenous markers, which could be stopped
after one subculturing step in unselective medium for plasmid loss.
In summary, the method here presented for multiple gene dis-
ruption and/or integration in A. gossypii offers advantages over the
existing methods by enabling the creation of mutants entirely free
of foreign genes and allowing the reuse of selection markers. The
set of disruption cassettes and plasmids constructed greatly
expand the possibilities for genetically engineer A. gossypii, being
these suitable for use in both laboratorial and industrial strains,
as they do not require any predetermined genetic background.
Furthermore, since the number of stable A. gossypii auxotrophic
strains currently available is limited, the strains generated here
are envisaged to be useful for future genetic engineering projects.
Efforts are now being made to develop a selection system based
on the complementation of these auxotrophic mutants.
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